International Randomized Double Blind Study Evaluating the Efficacy and the Safety of Clopidogrel Once Daily Versus Placebo in Neonates and Infants With Cyanotic Congenital Heart Disease Palliated With Systemic to Pulmonary Artery Shunt.

Trial Profile

International Randomized Double Blind Study Evaluating the Efficacy and the Safety of Clopidogrel Once Daily Versus Placebo in Neonates and Infants With Cyanotic Congenital Heart Disease Palliated With Systemic to Pulmonary Artery Shunt.

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Dec 2014

At a glance

  • Drugs Clopidogrel (Primary)
  • Indications Thrombosis
  • Focus Registrational; Therapeutic Use
  • Acronyms CLARINET
  • Sponsors Sanofi
  • Most Recent Events

    • 20 Jun 2013 Primary endpoint 'Treatment-failure-rate' has not been met.
    • 20 Jun 2013 Results published in the New England Journal of Medicine.
    • 13 Mar 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top